金属纳米佐剂用于肿瘤免疫治疗的研究进展
Advances of metal nanoadjuvant for cancer immunotherapy
-
摘要: 免疫治疗已成为继手术切除、化疗、放疗和靶向治疗之后的另一种有效的肿瘤治疗手段。然而, 由于肿瘤细胞免疫原性低及免疫抑制性肿瘤微环境, 抗原呈递细胞识别并处理肿瘤抗原效率低下, 进而导致细胞毒性T淋巴细胞激活与肿瘤浸润不足, 这在很大程度上影响了肿瘤免疫治疗的效果。近年来, 研究表明多种金属离子在激活先天免疫刺激及克服获得性免疫耐受方面具有突出的调节作用。基于此, 科学家们开发了一系列基于金属离子或金属纳米颗粒的纳米佐剂递送系统, 提高金属离子在肿瘤组织或淋巴器官内的靶向蓄积水平, 从而高效诱导肿瘤细胞免疫原性死亡或是直接激活抗原呈递细胞以启动抗肿瘤特异性免疫应答。本文首先简要概述了多种金属离子在抗肿瘤免疫调节中的作用, 随后总结了利用金属纳米佐剂递送系统实现高效抗肿瘤免疫治疗的研究进展, 最后并对该领域的主要挑战和可能发展方向进行了展望。Abstract: Immunotherapy has become another effective tumor treatment after surgical resection, chemotherapy, radiotherapy and targeted therapy. However, due to the low immunogenicity of tumor cells and immunosuppressive tumor microenvironment, antigen-presenting cells inefficiently process and present tumor antigens, thus leading to insufficient activation of cytotoxic T lymphocytes and tumor infiltration, which significantly affects the effectiveness of tumor immunotherapy. In recent years, it has been demonstrated that multiple metal ions exhibit distinguished modulatory effects in activating innate immune stimulation and conquering acquired immune tolerance. Based on this, scientists have designed a series of nano-adjuvant delivery systems with metal ions or metal nanoparticles to enhance the targeted accumulation of metal ions in tumor tissues or lymphoid organs for efficiently inducing immunogenic cell death or directly activating antigen-presenting cells to initiate anti-tumor specific immune response. This review briefly outlines the role of various metal ions in anti-tumor immunomodulation, summarizes the research progress in using metal nanoadjuvant delivery systems to achieve efficient anti-tumor immunotherapy, and provides foresight on the main challenges and potential directions in this field.
下载: